Focused on high‑growth tech
We map deep‑tech, healthtech, and software/AI to the right agencies and Canadian programs.
Software & AI
NSF (Project Pitch → invite), DoD (dual‑use/DSIP), and SR&ED credits; manage compute‑heavy R&D narratives with commercialization clarity.
Healthtech
NIH SBIR (Omnibus vs. Contracts), institute fit, regulatory readiness; align clinical evidence with funding milestones.
Cleantech
DOE/EPA/DoD pathways plus IRAP; cross‑border stacks that accelerate pilots and scale‑up.
Our Portfolio Approach
Full‑spectrum non‑dilutive strategy
One page, everything you need. We design and manage the portfolio, keep you compliant post‑award, build internal capability, and align R&D with commercialization.
Non‑Dilutive Funding Portfolio
We pursue 3–5 aligned opportunities in parallel across NSF, NIH, DoD and IRAP/SR&ED. Expect a 90‑day and 12‑month roadmap, reviewer‑first narratives, tight budgets, and a submission calendar that keeps you in motion.
Compliance & Post‑Award Finance
Win it, spend it right, stay audit‑ready. We set up allowability, time & effort, indirects, and reporting rhythms a CFO appreciates. We help you capture TABA where applicable and keep the trail clean for Phase II/III.
Workshops & Grant Readiness
Executive briefings for CEOs/boards and working sprints on SBIR/STTR mechanics, Specific Aims, commercialization narratives, and compliance best practices.
Non‑Dilutive Funding Portfolio
Milestone roadmaps, pricing & GTM, partner development, and investor narratives that explicitly connect non‑dilutive wins to valuation.
